http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-055629-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24e76490bed88751680a5fef9bc73892 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-12 |
| filingDate | 2006-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2007-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-055629-A1 |
| titleOfInvention | TOPICAL FORMULATIONS WITH O-DEMETILVENLAFAXINE (ODV) CONTENT OR ITS SALTS |
| abstract | The present discloses topical compositions comprising O-desmethylvenlafaxine (ODV), a selective serotonin and norepinephrine inhibitor, or a pharmaceutically acceptable salt thereof. In certain embodiments, the topical formulations herein contain one or more percutaneous / permucosal absorption enhancers. Methods for the preparation and use of these compositions for the treatment of various diseases and disorders such as vasomotor symptoms and pain are also presented. |
| priorityDate | 2005-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 25.